Xenon Pharmaceuticals (XENE) has released an update.
Xenon Pharmaceuticals, a company specializing in neurological and psychiatric treatments, is set to participate in the 23rd Annual Needham Virtual Healthcare Conference. During the April 11th event, Xenon’s leadership, including CEO Ian Mortimer and CFO Sherry Aulin, will discuss the company’s advancements and strategic direction. A webcast of their presentation will be available on Xenon’s website for both live viewing and replay.
For further insights into XENE stock, check out TipRanks’ Stock Analysis page.
